Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Michael Walter

Michael Walter
Managing Editor


Michael has more than 19 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

LATEST ARTICLES BY THIS AUTHOR

Blood pressure drug recalled due to failed test
CMS finalizes sweeping TAVR changes, including Medicare coverage for asymptomatic patients
A new CVD risk factor emerges: Too much light exposure at night is bad for the heart
Stryker recalls AEDs due to malfunction risk
FDA approves new device for capturing debris during TAVR
Heart failure before and after TAVR: New data point to ongoing concerns
FDA clears updates to new platform for cardiac imaging, visualization and navigation
Simple, safe and efficient: Veteran cardiologist takes an IVL-first approach for all calcium types
New heart drug from Novartis falls short in clinical trial: ‘Not the results we hoped for’
FDA approves new Abbott catheter capable of PFA and radiofrequency ablation

Pagination

    • First page « First
    • Previous page ‹ Previous
    • Page …2
    • Page 3
    • Page 4
    • Page 5
    • Current page 6
    • Page 7
    • Page 8
    • Page 9
    • Page 10 …
    • Next page Next ›
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme